dehydroevodiamine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; He, S; Sheng, J; Su, L; Wang, Y; Wu, Q | 1 |
| Chang, KA; Ha, S; Jeong, YH; Kim, HJ; Kim, HS; Lee, JH; Moon, C; Noh, SJ; Park, CH; Park, HJ; Shin, KY; Suh, YH; Yoo, J | 1 |
2 other study(ies) available for dehydroevodiamine and Disease Models, Animal
| Article | Year |
|---|---|
Dehydroevodiamine suppresses inflammatory responses in adjuvant-induced arthritis rats and human fibroblast-like synoviocytes.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Body Weight; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Female; Freund's Adjuvant; Gene Expression Regulation; Humans; Matrix Metalloproteinases; Rats; Synoviocytes | 2022 |
Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor.
Topics: Alkaloids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Avoidance Learning; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Models, Molecular; Mutation; Neuroprotective Agents; Reaction Time | 2016 |